Envoy Medical, Inc.

Envoy Medical, Inc. (Nasdaq: ANZU) reached the public markets through a business combination with Anzu Special Acquisition Corp I, a blank-check company that completed its initial public offering in 2021. The SPAC was sponsored by Anzu Partners, a life sciences and medical device-focused investment firm. Envoy Medical operates in the medical device sector, developing fully implantable hearing solutions including the Esteem implantable hearing device and the Acclaim cochlear implant system. The company filed an amended quarterly report, Form 10-Q/A, with the SEC on January 3, 2022, reflecting updates to its financials as a newly public entity. For complete filing history, SPAC analytics, and sponsor data on ANZU and thousands of other vehicles, sign up for full access at SpacDesk.